Resveratrol and Myopathy
INSERM UMRS 1124, Université Paris Descartes, Paris 75006, France
Author to whom correspondence should be addressed.
Nutrients 2016, 8(5), 254; https://doi.org/10.3390/nu8050254
Received: 22 February 2016 / Revised: 18 April 2016 / Accepted: 21 April 2016 / Published: 28 April 2016
(This article belongs to the Special Issue Selected Papers from Resveratrol Regional Meeting 2015)
Resveratrol is a natural polyphenolic compound produced by plants under various stress conditions. Resveratrol has been reported to exhibit antioxidant, anti-inflammatory, and anti-proliferative properties in mammalian cells and animal models, and might therefore exert pleiotropic beneficial effects in different pathophysiological states. More recently, resveratrol has also been shown to potentially target many mitochondrial metabolic pathways, including fatty acid β-oxidation or oxidative phosphorylation, leading to the up-regulation of the energy metabolism via signaling pathways involving PGC-1α, SIRT1, and/or AMP-kinase, which are not yet fully delineated. Some of resveratrol beneficial effects likely arise from its cellular effects in the skeletal muscle, which, surprisingly, has been given relatively little attention, compared to other target tissues. Here, we review the potential for resveratrol to ameliorate or correct mitochondrial metabolic deficiencies responsible for myopathies, due to inherited fatty acid β-oxidation or to respiratory chain defects, for which no treatment exists to date. We also review recent data supporting therapeutic effects of resveratrol in the Duchenne Muscular Dystrophy, a fatal genetic disease affecting the production of muscle dystrophin, associated to a variety of mitochondrial dysfunctions, which likely contribute to disease pathogenesis. View Full-Text►▼ Show Figures
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Bastin, J.; Djouadi, F. Resveratrol and Myopathy. Nutrients 2016, 8, 254.
AMA StyleShow more citation formats Show less citations formats
Bastin J, Djouadi F. Resveratrol and Myopathy. Nutrients. 2016; 8(5):254.Chicago/Turabian Style
Bastin, Jean; Djouadi, Fatima. 2016. "Resveratrol and Myopathy." Nutrients 8, no. 5: 254.
Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.